Adipocyte-derived PGE2 is required for intermittent fasting-induced Treg proliferation and improvement of insulin

Chunqing Wang1, Xing Zhang1, Liping Luo1

  • 1Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.

JCI Insight
|March 9, 2022
PubMed

Insights

Intermittent fasting (IF) benefits diabetes prevention by regulating cyclooxygenase-2 (COX-2) in white adipose tissue. This pathway influences immune cells, enhancing anti-inflammatory and insulin-sensitizing effects.

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Endocrinology

Background:

  • Intermittent fasting (IF) shows promise for diabetes prevention, but its mechanisms are unclear.
  • Cyclooxygenase-2 (COX-2) expression is reduced in obese human white adipose tissue (WAT).

Purpose of the Study:

  • To elucidate the role of COX-2 in white adipose tissue (WAT) in mediating the metabolic benefits of intermittent fasting (IF).

Main Methods:

  • Investigated COX-2 expression in obese human WAT and IF-treated obese mice.
  • Utilized adipocyte-specific COX-2 knockout mice to assess immune cell populations and metabolic parameters.
  • Examined the effect of prostaglandin E2 (PGE2) on regulatory T cell (Treg) proliferation in vitro and in vivo.
  • Assessed the impact of Treg inactivation on IF-induced metabolic improvements.

Main Results:

  • IF upregulated COX-2 expression in mouse WAT.
  • Adipocyte COX-2 deficiency altered immune cell composition in WAT and attenuated IF's anti-inflammatory and insulin-sensitizing effects.
  • Adipocyte-derived PGE2 promoted Treg proliferation and restored IF benefits in COX-2 deficient mice.
  • Treg inactivation diminished IF's metabolic advantages, which were rescued by PGE2.

Conclusions:

  • Adipocyte COX-2 is crucial for Treg proliferation.
  • Adipocyte-derived PGE2 mediates the type 2 immune response and metabolic benefits of IF.
  • Targeting the COX-2/PGE2/Treg axis may offer therapeutic strategies for metabolic diseases.